Research Article
Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney Transplantation
Table 1
Study group demographics based on stent placement.
| Demographic variables | Stent placed | No stent | value | Total number 621 | 295 (47.5%) | 326 (52.5%) |
| Age group | | | 0.06 | <18 yr | 17 (6%) | 15 (5%) | 18–50 yr | 139 (47%) | 124 (39%) | >51 yr | 139 (47%) | 187 (75%) | Donor source | | | 0.01 | Deceased donor | 231 (80%) | 300 (92%) | Living donor | 64 (20%) | 26 (8%) | Gender | | | 0.87 | Male | 190 (64%) | 208 (64%) | Female | 105 (36%) | 118 (36%) | Race | | | 0.59 | White | 171 (58%) | 199 (61%) | African-American | 99 (33%) | 97 (30%) | Others | 25 (8%) | 30 (9%) | Induction | | | 0.23 | Thymoglobulin | 81 (27%) | 58 (18%) | Basiliximab | 212 (72%) | 262 (80%) | Missing | 2 (0.7%) | 6 (1.8%) | Cold ischemia time | | | 0.02 | <12 h | 91 (31%) | 58 (18%) | 13–24 h | 103 (35%) | 113 (35%) | >24 h | 99 (33%) | 149 (45%) | Missing | 2 (0.7) | 6 (1.8%) | Graft function | | | 0.02 | Immediate | 180 (61%) | 166 (51%) | Delayed | 112 (38%) | 155 (47.5%) | Missing | 3 (1%) | 5 (1.5%) | BK viruria | 75/250 (30.0%) | 62/279 (22.2%) | 0.04 | 137/529 (25.8%) | BK viremia | 63/289 (21.8%) | 52/317 (16.4%) | 0.05 | 115/606 (19.0%) |
|
|